The Middle East healthcare industry continues to advance in its new era of transformation and integration, driven by digital health, local manufacturing, cross-border collaborations and the rapid rise of AI and robotics. According to Deloitte, the region’s medical robotics sector is expected to expand from $626 million in 2024 to more than $811 million by 2028.
From Abu Dhabi’s PureHealth’s global expansion to Riyadh’s SPIMACO launching Saudi Arabia’s first high-potent pharmaceutical manufacturing facility, regional players are scaling up. Pharmaceutical and technology leaders deepened partnerships with governments, advancing national visions and localization goals.
This year’s Forbes Middle East Healthcare Leaders highlights changemakers, executives, founders, and shareholders redefining the region’s healthcare ecosystem for the decade ahead. The 2025 edition highlights 50 healthcare leaders who are founders and shareholders, together with 100 top executives and CEOs steering the region’s largest and most influential healthcare companies.
Topping the Shareholders list are Shaista Asif, Cofounder and Group CEO of PureHealth, Sulaiman Al Habib, Founder and Chairman of Dr. Sulaiman Al Habib Medical Services Group (HMG), and Said Darwazah Executive Chairman of of Hikma Pharmaceuticals.